These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2664377)

  • 41. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 42. [Host-graft interactions after allogenic bone marrow transplantation; choice of donor].
    Alby N; Bernard A; Devergie A; Goldman JM; Hervé P; Maraninchi P; Raffoux C; Gluckman E
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):55-64. PubMed ID: 3290840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Morphological and cytochemical characteristics of cells evoking "graft versus host" reaction in transplantation of allogenic bone marrow to irradiated dogs].
    Samoĭlina NL; Totskaia AA; Chertkov IL
    Tsitologiia; 1967 Apr; 9(4):379-87. PubMed ID: 4864554
    [No Abstract]   [Full Text] [Related]  

  • 44. Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells.
    Barese C; Pech N; Dirscherl S; Meyers JL; Sinn AL; Yoder MC; Goebel WS; Dinauer MC
    Stem Cells; 2007 Jun; 25(6):1578-85. PubMed ID: 17347493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival.
    Popitz-Bergez FA; Sakamoto K; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Gress RE; Sachs DH
    Transplantation; 1988 Jan; 45(1):27-31. PubMed ID: 3122386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
    Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Stem cell transplantation--more than bone marrow transplantation].
    Egeland T; Thorsby E
    Nord Med; 1995; 110(12):307-9. PubMed ID: 8524629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia].
    Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic bone marrow transplantation of chronic myeloid leukemia from an HLA-matched unrelated donor with the beta-thalassemic trait.
    Sue YC; Liu TC; Chang CS; Huang SM; Chen TP; Lin SF
    Int J Hematol; 1999 Apr; 69(3):200-2. PubMed ID: 10222660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic and functional alterations of recipient lymphocytes after transfusion of UV-irradiated and normal blood--implications for marrow transplantation.
    Deeg HJ; Aprile J; Severns E; Rajantie J; Schmidt E; Raff RF; Green KE; Storb R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2709-14. PubMed ID: 2950640
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic markers in human bone marrow transplantation.
    Blume KG; Beutler E; Bross KJ; Schmidt GM; Spruce WE; Teplitz RL
    Am J Hum Genet; 1980 May; 32(3):414-9. PubMed ID: 6992565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lewis substance in a human marrow-transplantation chimaera.
    Swanson J; Crookston MC; Yunis E; Azar M; Gatti RA; Good RA
    Lancet; 1971 Feb; 1(7695):396. PubMed ID: 4100230
    [No Abstract]   [Full Text] [Related]  

  • 54. [Morphological aspects of "immunologically competent" cells during allogenic graft reactions].
    BINET JL; MATHE G; SEMAN G; KINSKY L; AMIEL JL
    Nouv Rev Fr Hematol; 1961; 1():887-99. PubMed ID: 13869252
    [No Abstract]   [Full Text] [Related]  

  • 55. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic marker changes after bone marrow transplantation and problems in forensic medicine.
    Ikemoto S; Kajii E; Tsuchida S; Nishiumi E
    Acta Med Leg Soc (Liege); 1989; 39(2):471-5. PubMed ID: 2535398
    [No Abstract]   [Full Text] [Related]  

  • 57. [The role of HLA in bone marrow transplantation].
    Harada M; Mori T; Matsuda T
    Rinsho Ketsueki; 1985 Dec; 26(12):1927-35. PubMed ID: 3914558
    [No Abstract]   [Full Text] [Related]  

  • 58. [Donor selection for allogenic bone marrow transplantation from 1991 to 1995. (The Prague Center for Bone Marrow Transplantation)].
    Korínková P; Matĕjková E; Vítek A
    Cas Lek Cesk; 1996 Jun; 135(12):389-92. PubMed ID: 8706078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Engraftment markers in allogenic bone marrow graft].
    Ribera JM; Feliu E
    Med Clin (Barc); 1989 Apr; 92(16):612-4. PubMed ID: 2664377
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.